The proportion of CD4+ and CD8+ TILs in distinct tumour tissues is different, CD4+ TILs are related to humoral immunity, CD8+ TILs are related to cellular immunity, and CD8+ TILs play a major killing role in NSCLC [64, 65]. This evidence concerns the gene CD8A and neoplasm.